The tale of TILs in breast cancer A report from The International Immuno-Oncology Biomarker Working Group /
The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potenti...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2021
|
| Sorozat: | NPJ BREAST CANCER
7 No. 1 |
| Tárgyszavak: | |
| doi: | 10.1038/s41523-021-00346-1 |
| mtmt: | 32552869 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/25644 |